LINUO, founded in 1995, is a recognized name in the pharma glass packaging industry. With over 30 years of experience, the company specializes in the development of glass materials and holds more than 130 patents. In 2021, LINUO was listed on the ChiNext board of the Shenzhen Stock Exchange, further advancing its position in the market.
Experience in Pharma Glass Packaging
With three decades of experience, LINUO has developed a strong presence in the field of pharma glass packaging. The company focuses on providing reliable and efficient packaging solutions that meet the needs of the pharmaceutical industry. Its products are designed to ensure the safety and stability of pharmaceutical products throughout their lifecycle.
Innovation and Patented Technologies
LINUO has made significant strides in research and development, holding over 130 patents for its technologies. These patents cover various aspects of pharma glass packaging, including glass formulations and packaging designs. The company’s focus on innovation has allowed it to remain competitive and provide packaging solutions that meet industry standards.
LINUO Goes Public
In November 2021, LINUO was successfully listed on the ChiNext board of the Shenzhen Stock Exchange under the stock code 301188. This step highlights the company’s financial stability and its continued focus on the growth of its pharma glass packaging business.
Conclusion
With 30 years of experience, over 130 patents, and a successful public listing, LINUO remains a significant player among medical packaging manufacturers. The company continues to offer high-quality packaging solutions to the pharmaceutical industry while maintaining a focus on innovation and reliability.
